Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 5,280 Shares

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 5,280 shares of the firm’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $44.02, for a total value of $232,425.60. Following the transaction, the chief executive officer owned 33,840 shares in the company, valued at approximately $1,489,636.80. This trade represents a 13.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Jack Bendheim also recently made the following trade(s):

• On Tuesday, November 25th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.93, for a total value of $309,267.20.
• On Monday, November 17th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.56, for a total value of $235,276.80.
• On Thursday, November 13th, Jack Bendheim sold 8,801 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.47, for a total value of $391,380.47.
• On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.23, for a total transaction of $974,073.28.
• On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.29, for a total transaction of $1,734,742.87.
• On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $42.86, for a total value of $150,867.20.
• On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.10, for a total value of $151,712.00.
• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.07, for a total value of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.56, for a total value of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total value of $141,433.60.

Phibro Animal Health Trading Down 2.5%

Shares of Phibro Animal Health stock opened at $43.23 on Thursday. The company has a market cap of $1.75 billion, a price-to-earnings ratio of 36.64, a PEG ratio of 1.24 and a beta of 0.81. Phibro Animal Health Corporation has a 1 year low of $16.16 and a 1 year high of $46.42. The company’s fifty day simple moving average is $40.89 and its 200-day simple moving average is $33.18. The company has a current ratio of 2.76, a quick ratio of 1.25 and a debt-to-equity ratio of 2.46.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. The company had revenue of $363.89 million for the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. As a group, sell-side analysts expect that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 17th. Investors of record on Wednesday, November 26th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.1%. The ex-dividend date is Wednesday, November 26th. Phibro Animal Health’s payout ratio is currently 28.92%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. National Bank of Canada FI bought a new stake in shares of Phibro Animal Health in the 1st quarter worth about $30,000. Financial Management Professionals Inc. bought a new position in Phibro Animal Health during the 2nd quarter valued at about $32,000. Hughes Financial Services LLC acquired a new position in Phibro Animal Health in the third quarter valued at about $40,000. iSAM Funds UK Ltd bought a new stake in Phibro Animal Health during the third quarter worth about $61,000. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Phibro Animal Health by 7,671.4% during the second quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock worth $69,000 after buying an additional 2,685 shares in the last quarter. 99.34% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Zacks Research lowered Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Monday, November 10th. Bank of America upped their target price on Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a research note on Friday, August 29th. Morgan Stanley set a $34.00 price target on shares of Phibro Animal Health in a research note on Thursday, August 28th. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday. Finally, JPMorgan Chase & Co. increased their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $31.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.